Vcanbio Cell & Gene Engineering Corporation
Provider of bioreagents for genomic research and cell culture
About This Fund
Vcanbio Cell & Gene Engineering Corporation is a corporate investor (Bioreagents,) founded in 2009 and headquartered in Tianjin, china. Provider of bioreagents for genomic research and cell culture. The company is engaged in the detection and storage of stem cell sources. Through its subsidiaries, the company is primarily involved in the preparation, detection, and storage of cells, genes, cell culture, as well as the production and sale of cytokines culture solutions and cosmetics, among others. The company operates its business primarily in the domestic market. Practice areas include Life Sciences. The firm operates as Genomics and Life Sciences Platforms and Tools.
Investment Focus
Preparing to pitch Vcanbio Cell & Gene Engineering Corporation?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →